We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Journal Scan / Research · July 29, 2021

Immune-Related Adverse Events Effect in Metastatic Melanoma Treated With PD-1 Inhibitors

Melanoma research

 

Additional Info

Melanoma research
Impact of The Development of Immune Related Adverse Events in Metastatic Melanoma Treated with PD-1 Inhibitors
Melanoma Res. 2021 Jun 01;31(3)258-263, RG Holstead, BA Kartolo, WM Hopman, TD Baetz

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading